Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6793726

O=C(O)C(F)(F)F.O=C1c2c3c(nn2CCN1CCCc1ccccc1)-c1ccncc1CC3

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 3/20 0.34
HDAC3 O15379 3/20 0.34
HDAC4 P56524 3/20 0.34
HDAC1 Q13547 3/20 0.34
HDAC7 Q8WUI4 3/20 0.34
HDAC2 Q92769 3/20 0.34
HDAC10 Q969S8 3/20 0.34
HDAC11 Q96DB2 3/20 0.34
HDAC8 Q9BY41 3/20 0.34
HDAC6 Q9UBN7 3/20 0.34
HDAC9 Q9UKV0 3/20 0.34
HDAC5 Q9UQL6 3/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALOX15 P16050 1/20 0.34
ROCK2 O75116 2/20 0.34
SCD O00767 1/20 0.34
AURKA O14965 1/20 0.33
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6798947 0.87 GRIN2B (0.34) NAMPTHDAC3HDAC4HDAC1HDAC7
Trifluoroacetic Acid SCHEMBL6792249 0.83 ROCK2 (0.34) ROCK2DHPSS1PR1
Hydrochloric Acid SCHEMBL6788008 0.79 TDP1 (0.33) CDK2
SCHEMBL6790941 0.79 RIPK3 (0.32)
Hydrochloric Acid SCHEMBL6794539 0.79 PDPK1 (0.31) CDK2
Hydrochloric Acid SCHEMBL4263968 0.74 PDPK1 (0.33) NAMPTCDK2
Trifluoroacetic Acid SCHEMBL4263119 0.73 ROCK2 (0.39) NAMPTROCK2AURKACCNA2CDK2
Trifluoroacetic Acid SCHEMBL1655450 0.73 NAMPT (0.41) NAMPTROCK2AURKACCNA2CDK2
SCHEMBL6798659 0.73 SIGMAR1 (0.36)
Trifluoroacetic Acid SCHEMBL1656607 0.72 CDK2 (0.36) NAMPTROCK2AURKACCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040127492-A1 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 PHARMACIA CORPORATION 2004-07-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127492-A1 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 MKNK2, MAPKAPK2, MAP3K2 NAMPT 658/4885HDAC3 972/4885HDAC4 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.